4-Star Stocks Poised to Pop: PetMed Express


Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, nationwide pet pharmacy PetMed Express (NAS: PETS) has earned a respected four-star ranking.

With that in mind, let's take a closer look at PetMed's business and see what CAPS investors are saying about the stock right now.

PetMed facts

Headquarters (founded)

Pompano Beach, Fla. (1996)

Market Cap

$194.8 million


Internet retail

Trailing-12-Month Revenue

$233.6 million


CEO Menderes Akdag (since 2001)
CFO Bruce Rosenbloom (since 2001)

Return on Equity (average, past 3 years)



$67.7 million / $0

Dividend Yield



KV Vet Supply

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 893 members who have rated PetMed believe the stock will outperform the S&P 500 going forward.

A few months ago, one of those bulls, All-Star TSIF, succinctly summed up the bull case for our community:

PetMed Express is a small cap with some room to grow. ... I understand it is starting to face some competition, especially from Amazon, but if I have a pet that needs meds, where am I going to look first for them, the trusted pharmacy, or the dollar store? I realize that if you can compare brand to brand that some people will shop around, but it's not a given that Amazon can take market share just on cost. ... They have no debt and adequate cash/cash flow that any real issues should become apparent in advance of any further hammering.

If you want market-beating returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its four-star rating, PetMed may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow theTrackPoisedToCAPS account.

The article 4-Star Stocks Poised to Pop: PetMed Express originally appeared on Fool.com.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Amazon.com. Motley Fool newsletter services have recommended buying shares of Amazon.com. Try any of our Foolish newsletter services free for 30 days.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.